AlphaLife Sciences hosted a DIA webinar panel on September 17 to explain what actually changed, and where CMC teams should still be cautious.
Published
Signal category
Presence & Recognition
Quote
“Jean-Marie Geoffroy has watched this from the inside for decades. Former VP, Sterile Injectables Design at Pfizer. Former Director and Senior Fellow at Takeda. Now advising sponsors through Cachet Pharma Consulting.”
— AlphaLife Sciences team
Company
- Industry
- Software Development
- Location
- Iselin, US
- Company size
- 29 employees
AlphaLife Sciences, a leader in Agentic AI-driven clinical development, advances automated medical writing and regulatory documentation through its AuroraPrime platform, driving efficiency across therapeutic areas. As Microsoft's Global AI Content Automation Partner for Life Sciences, and with support from Johnson & Johnson Innovation JLABS, Google for Startups, the Nvidia Inception Program, and Veeva's AI Program, AlphaLife Sciences accelerates drug R&D and regulatory submissions, helping to deliver life-saving treatments worldwide.